X0306 4 2017-12-19 0001099800 Edwards Lifesciences Corp EW 0001204551 MUSSALLEM MICHAEL A ONE EDWARDS WAY IRVINE CA 92614 1 1 Chairman & CEO Common Stock 2017-12-19 4 M 0 32800.0000 44.6150 A 74130.8200 D Common Stock 2017-12-19 4 S 0 300.0000 115.4167 D 73830.8200 D Common Stock 2017-12-19 4 S 0 32500.0000 114.8159 D 41330.8200 D Common Stock 123931.0030 I 401(k) Common Stock 698095.0000 I By Living Trust Employee Stock Option (Right to Acquire) 44.6150 2017-12-19 4 M 0 32800.0000 0.0000 D 2011-06-12 2018-05-11 Common Stock 32800.0000 151000.0000 D The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 27, 2017. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the Reporting Person. This transaction was executed in multiple trades at prices ranging from $115.35 to $115.47. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $114.35 to $115.34. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. Shares represented on the most recent statement of Issuer's 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equity to share equivalents. Linda J. Park, Attorney-in-Fact 2017-12-20